A new University of Manchester study finds that analysing skin sebum via non-invasive swabs can identify Parkinson's biomarkers up to seven years before motor symptoms emerge, offering hope for earlier detection and intervention.
The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s
My PD Journey is a multi-stakeholder...
Emory University’s Stuart Zola considers the case for classifying Alzheimer’s disease as a spectrum disorder and the promise of precision medicine as an intervention.
The defect that causes Huntington's disease has been corrected in patients for the first time with an experimental drug
Experts believe that the new experimental drug, which...
Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition
Alzheimer’s disease...
Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s
Frederic Destrebecq, Vinciane Quoidbach and Alison Turner at the European Brain Council discuss improvements in stroke care, awareness-raising and early detection
Stroke is a leading...
Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research
Parkinson's disease is a slow but progressive...
The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance
This will...
Professor Serena Carra and her collaborators are investigating the important role of small heat shock proteins in age-related neurodegenerative diseases
Cells are frequently exposed to...
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders
